Leukemia Diagnosis and Treatment Center

白血病诊疗中心 · Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin

The Leukemia Diagnosis and Treatment Center focuses on the clinical care and research of leukemia. The team uses risk-stratified treatment based on prognostic factors to improve outcomes for acute leukemia. Protocols include homoharringtonine combined with anthracyclines, and intermediate-dose cytarabine for acute myeloid leukemia. These approaches have been adopted into national clinical guidelines. The center also develops CD19 CAR-T cell therapy (HI19a-4-1BB-ζ). An Phase I trial for this therapy began recruiting in January 2020 and has completed dose escalation. A Phase II trial was expected to start in early 2021. Research findings have been published in journals such as Clinical Cancer Research and Haematologica.

Conditions and treatments

Key facts

Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.

SpecialtyHematologic Oncology
Doctors listed17
Chief physicians—

We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.

Need a specialist's opinion?

Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.

Contact us